Today's Low
₹ 1,753.00
Today's High
₹ 1,784.00
52 Weeks Low
₹ 1,130.00
52 Weeks High
₹ 3,179.70
Lower
₹ 1,405.40
Upper
₹ 2,108.00
Gland Pharma Limited engages in the development, manufacture, and marketing of injectable-focused generic liquid parenteral products. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others. It offers its products under various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, pain management, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, orthopedics, hematinic, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business to business in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.
No Data Found
No of shares Outstanding
EPS-TTM
Face Value
Book Value
Net Asset Value
ROE
ROA
ROCE
Dividend Yield
Total Debt
Sales Growth
PAT Growth
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|
Total Current Assets | 6,900.8 | 5,852.1 | 5,123.6 | 2,846.3 |
Total Non-Current Assets | 1,876.7 | 1,981.5 | 1,372.4 | 1,239.8 |
Total Assets | 8,777.5 | 7,833.6 | 6,496.1 | 4,086.0 |
Total Current Liabilities | 729.1 | 582.0 | 512.5 | 359.0 |
Total Non-Current Liabilities | 89.7 | 94.0 | 80.3 | 80.8 |
Shareholder's Funds | 7,958.7 | 7,157.6 | 5,903.2 | 3,646.2 |
Total Liabilities | 8,777.5 | 7,833.6 | 6,496.1 | 4,086.0 |
The Industry Current Ratio stands at 2.31, vs the Current Ratio of 7.93, which results in a Positive aspect.
The Industry Price to BV stands at 6.03, vs the Price to BV of 3.41, which results in a Negative aspect.
The Industry Debt to Equity Ratio stands at 0.22, vs the Debt to Equity Ratio of 0.00, which results in a Positive aspect.
The Industry Quick Ratio stands at 1.60, vs the Quick Ratio of 5.82, which results in a Positive aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|
Total Income | 3,524.5 | 4,400.7 | 3,462.9 | 2,633.2 |
Total Expenditure | 2,611.6 | 2,890.6 | 2,160.7 | 1,677.8 |
Operating Profit(Excl OI) | 1,153.3 | 1,734.1 | 1,437.0 | 1,094.6 |
Add: Other Income | 240.5 | 223.9 | 134.8 | 139.2 |
Operating Profit | 1,153.3 | 1,734.1 | 1,437.0 | 1,094.6 |
Less: Interest | 7.5 | 5.2 | 3.4 | 7.2 |
PBDT | 1,145.9 | 1,728.9 | 1,433.6 | 1,087.5 |
Less: Depreciation Amortization | 146.7 | 110.3 | 98.8 | 94.6 |
PBT & Exceptional Items | 999.1 | 1,618.6 | 1,334.8 | 992.9 |
Less: Exceptional Income Expenses | 55.5 | 0.0 | 0.0 | 0.0 |
Profit Before Tax | 1,054.6 | 1,618.6 | 1,334.8 | 992.9 |
Less: Taxation | 273.5 | 406.9 | 337.9 | 220.0 |
Profit After Tax | 781.0 | 1,211.7 | 997.0 | 772.9 |
Earnings Per Share | 4.7 | 7.4 | 6.1 | 5.0 |
The Industry PAT Margin stands at 9.77, vs the PAT Margin of 29.35, which results in a Positive aspect.
The Industry PAT Growth stands at 32.18, vs the PAT Growth of 0.00, which results in a Negative aspect.
The Industry PE Ratio stands at 42.56, vs the PE Ratio of 44.05, which results in a Positive aspect.
The Industry Dividend Yield stands at 0.60, vs the Dividend Yield of 0.00, which results in a Negative aspect.
Particulars | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
---|---|---|---|---|
Profit Before Tax | 1,054.6 | 1,618.6 | 1,334.8 | 992.9 |
Tax Paid | -310.9 | -406.5 | -311.4 | -244.1 |
Adjustment | 38.2 | -28.3 | 17.3 | 32.1 |
Changes In Working Capital | 1,054.6 | 1,618.6 | 1,334.8 | 992.9 |
Cash Flow after changes in Working Capital | 674.8 | 1,197.3 | 916.4 | 945.1 |
Cash Flow from Operating Activities | 364.0 | 790.8 | 604.9 | 700.9 |
Cash Flow from Investing Activities | 1,208.2 | -1,002.6 | -1,524.0 | -766.1 |
Cash Flow from Financing Activities | 14.9 | 34.9 | 1,238.5 | -6.9 |
Net Cash Inflow / Outflow | 1,587.1 | -177.0 | 319.4 | -72.0 |
Opening Cash & Cash Equivalents | 318.8 | 492.5 | 169.5 | 236.4 |
Closing Cash & Cash Equivalent | 1,908.9 | 318.8 | 492.5 | 169.5 |
The Industry PFCF Ratio stands at 25.12, vs the PFCF Ratio of 0.00, which results in a Negative aspect.
The Industry PCF RATIO stands at 24.29, vs the PCF RATIO of 0.00, which results in a Negative aspect.
Particulars | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 15,451.6 | 13,734.2 | 12,086.9 | 7,850.1 | 9,382.9 | 10,444.0 | 8,569.0 | 11,030.1 | 10,633.3 | 10,804.7 | 11,539.0 | 8,877.5 |
Total Income | 15,825.5 | 14,265.8 | 12,462.4 | 8,239.5 | 9,998.0 | 11,100.3 | 9,312.9 | 11,682.5 | 11,089.9 | 11,316.7 | 12,157.4 | 9,349.6 |
Total Expenditure | 11,887.7 | 10,493.5 | 9,147.4 | 6,165.9 | 6,487.2 | 7,475.5 | 5,869.8 | 7,546.6 | 7,144.1 | 7,038.7 | 7,176.2 | 5,600.8 |
PBIDT (Excl OI) | 3,563.9 | 3,240.8 | 2,939.5 | 1,684.2 | 2,895.7 | 2,968.5 | 2,699.2 | 3,483.5 | 3,489.2 | 3,766.0 | 4,362.8 | 3,276.7 |
Other Income | 373.9 | 531.6 | 375.4 | 389.4 | 615.1 | 656.2 | 743.9 | 652.3 | 456.7 | 512.0 | 618.4 | 472.1 |
Operating Profit | 3,937.8 | 3,772.3 | 3,315.0 | 2,073.6 | 3,510.8 | 3,624.8 | 3,443.1 | 4,135.9 | 3,945.8 | 4,278.0 | 4,981.2 | 3,748.9 |
Interest | 52.8 | 60.5 | 49.2 | 22.0 | 26.2 | 17.2 | 9.0 | 20.3 | 11.8 | 10.2 | 10.0 | 10.2 |
Exceptional Items | 0.0 | 0.0 | 0.0 | -564.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
PBDT | 3,885.0 | 3,711.9 | 3,265.8 | 1,486.9 | 3,484.6 | 3,607.5 | 3,434.1 | 4,115.6 | 3,934.0 | 4,267.8 | 4,971.2 | 3,738.7 |
Depreciation | 1,053.4 | 813.0 | 653.2 | 375.4 | 376.1 | 366.7 | 349.1 | 310.8 | 278.3 | 261.1 | 252.8 | 249.2 |
Profit Before Tax | 2,831.6 | 2,898.9 | 2,612.7 | 1,111.5 | 3,108.5 | 3,240.8 | 3,085.0 | 3,804.8 | 3,655.6 | 4,006.7 | 4,718.4 | 3,489.4 |
Tax | 913.0 | 958.1 | 671.6 | 324.7 | 789.0 | 828.4 | 793.3 | 945.8 | 925.3 | 985.8 | 1,211.9 | 885.3 |
Provisions and contingencies | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Profit After Tax | 1,918.6 | 1,940.8 | 1,941.0 | 786.8 | 2,319.5 | 2,412.4 | 2,291.7 | 2,859.0 | 2,730.3 | 3,020.8 | 3,506.5 | 2,604.1 |
Net Profit | 1,918.6 | 1,940.8 | 1,941.0 | 786.8 | 2,319.5 | 2,412.4 | 2,291.7 | 2,859.0 | 2,730.3 | 3,020.8 | 3,506.5 | 2,604.1 |
ADDITIONAL INFOS: | ||||||||||||
Equity Capital | 164.7 | 164.7 | 164.7 | 164.7 | 164.7 | 164.7 | 164.7 | 164.3 | 164.3 | 164.2 | 163.9 | 163.6 |
Reserves | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
EPS | 11.7 | 11.8 | 11.8 | 4.8 | 14.1 | 14.7 | 13.9 | 17.4 | 16.6 | 18.4 | 21.4 | 15.9 |
Operating Profit Margin | 25.5 | 27.5 | 27.4 | 26.4 | 37.4 | 34.7 | 40.2 | 37.5 | 37.1 | 39.6 | 43.2 | 42.2 |
Net Profit Margin | 12.4 | 14.1 | 16.1 | 10.0 | 24.7 | 23.1 | 26.7 | 25.9 | 25.7 | 28.0 | 30.4 | 29.3 |
The Industry Net Sales Growth stands at 11.07, vs the Net Sales Growth of 0.00, which results in a Negative aspect.
The Industry Mcap Growth stands at 19.69, vs the Mcap Growth of 0.00, which results in a Negative aspect.
Type | Classic | Woodie | Camarilla |
---|---|---|---|
R4 | 1,851.00 | 1,891.83 | 1,787.64 |
R3 | 1,827.23 | 1,829.15 | 1,775.62 |
R2 | 1,803.47 | 1,804.43 | 1,771.61 |
R1 | 1,783.53 | 1,785.45 | 1,767.61 |
Pivot | 1,759.77 | 1,760.73 | 1,759.77 |
S1 | 1,739.83 | 1,741.75 | 1,759.59 |
S2 | 1,716.07 | 1,717.03 | 1,755.59 |
S3 | 1,696.13 | 1,698.05 | 1,751.58 |
S4 | 1,676.20 | 1,629.63 | 1,739.57 |
(All Values are in INR)
1 Day
1 Week
1 Month
Stoch RSI
36.77
Neutral
RSI
46.00
Neutral
ROC
-0.98
Bearish
UltimateOscillator
54.27
Neutral
Williams Indicator
-64.53
Neutral
CCI Indicator
-17.19
Neutral
MACD
-1,590.66
Bearish
Stochastic Indicator
32.64
Neutral
ATR
62.22
High Volatility
Ex-Date | Ratio | Record Date |
---|
Ex-Date | Ratio | Record Date |
---|
Announcement Date | Dividend Amount | Dividend Percentage of FV | Dividend Type |
---|
Date Of Conduct | Board Meeting Details |
---|---|
14-02-2024 | Quarterly Results |
06-11-2023 | Quarterly Results |
07-08-2023 | Quarterly Results |
07-08-2023 | |
18-05-2023 | A.G.M. |
18-05-2023 | Audited Results |
23-01-2023 | Quarterly Results |
26-10-2022 | Quarterly Results |
20-07-2022 | Quarterly Results |
19-05-2022 | Audited Results |
21-01-2022 | Quarterly Results |
22-10-2021 | Quarterly Results |
21-07-2021 | Quarterly Results |